作者: M. Pfaller , L. Boyken , R. Hollis , J. Kroeger , S. Messer
DOI: 10.1128/JCM.02432-10
关键词:
摘要: ABSTRACT We compared EUCAST and CLSI antifungal susceptibility testing methods for itraconazole, posaconazole, voriconazole by 245 Aspergillus clinical isolates. The essential agreement (EA) between was excellent: 100% (itraconazole), 98.4% (posaconazole), 99.6% (voriconazole) assessing EA at ±2 dilutions 87.7% 96.3% ±1 dilution.